Seventy participants (mean (s.d.) age = 47.3 (10.3) years, 58 (82.9%) female and 12 (17.1%) male) were randomized to receive 2.4 mg semaglutide ( n = 35) or placebo ( n = 35)
Containing the active ingredient, semaglutide, Wegovy is classified as a glucagon-like peptide-1 (GLP-1) receptor agonist that works to suppress your appetite, reduce food cravings, and support weight loss
This hormone helps regulate blood sugar and appetite
This diet had you eating yogurt at least twice a day
If you have severe abdominal pain, fever, vomiting, or signs of dehydration, seek urgent care
The formula is simple but unforgiving if you get it wrong: dose (mg) divided by concentration (mg/mL) multiplied by 100 equals units on syringe